Antimicrobial Agents and Chemotherapy · 2015 · 128 citations · 7 references
Life SciencesMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DiscoveryStructure-activity RelationshipsAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsEfflux-mediated ResistanceMultidrug ResistanceAntibiotic DiscoveryEfflux-mediated Tetracycline ResistanceResistance Mechanisms In Gram-positive BacteriaResistance Mechanisms In StaphylococciTetracycline AntibioticsTetracycline DerivativesTetracycline Resistance Mechanisms
A series of novel tetracycline derivatives were synthesized with the goal of creating new antibiotics that would be unaffected by the known tetracycline resistance mechanisms. New C-9-position derivatives of minocycline (the aminomethylcyclines [AMCs]) were tested for in vitro activity against Gram-positive strains containing known tetracycline resistance mechanisms of ribosomal protection (Tet M in Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pneumoniae) and efflux (Tet K in S. aureus and Tet L in E. faecalis). A number of aminomethylcyclines with potent in vitro activity (MIC range of ≤0.06 to 2.0 μg/ml) were identified. These novel tetracyclines were more active against one or more of the resistant strains than the reference antibiotics tested (MIC range, 16 to 64 μg/ml). The AMC derivatives were active against bacteria resistant to tetracycline by both efflux and ribosomal protection mechanisms. This study identified the AMCs as a novel class of antibiotics evolved from tetracycline that exhibit potent activity in vitro against tetracycline-resistant Gram-positive bacteria, including pathogenic strains of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE). One derivative, 9-neopentylaminomethylminocycline (generic name omadacycline), was identified and is currently in human trials for acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
7
S. Ansar Ahmed, Robert M. Gogal, Jane E. Walsh · Journal of Immunological Methods · 1994 · 1.4K citations
Kevin P. Connors, Seth T. Housman, J. Samuel Pope et al. · Antimicrobial Agents and Chemotherapy · 2014 · 111 citations · Full text